Guy Kantor

38 papers receiving 2.8k citations

Guy Kantor's Hit Papers

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial 2019 · 439 citations
4390+3+6Years since publication100200300400

Peers

Guy Kantor
Comparison fields: 5 of 79
  • Genetics 1.1k
  • Pulmonary and Respiratory Medicine 1.1k
  • Radiation 149
  • Biomaterials 164
  • Oncology 174
Replace Sunil P. P. Gulavita with:
Sunil P. P. Gulavita Canada
Daniel N. Cagney United States
Stephanie E. Weiss United States
Christopher D. Corso United States
Mario Balducci Italy
A. Gabriella Wernicke United States
Guido Sotti Italy
Matthew C. Foote Australia
J. Biau France
Roshan Sudhir Prabhu United States
Guy Kantor relative to Sunil P. P. Gulavita Canada Sunil P. P. Gulavita's profile →
Citations per field
00.5×1.5×2.2×
Sunil P. P. Gulavita · 1×
Citations per year

Countries citing papers authored by Guy Kantor

Since Specialization
Citations

This map shows the geographic impact of Guy Kantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Kantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Kantor more than expected).

Fields of papers citing papers by Guy Kantor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Kantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Kantor. The network helps show where Guy Kantor may publish in the future.

Co-authors

The 25 scholars most cited alongside Guy Kantor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guy Kantor Line = papers co-authored together Guy Kantor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007620
2
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
Hit paper breakdown →
2019439
3
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Hit paper breakdown →
2016405
4 2001371
5 2016202
6 2016109
7 200295
8 201278
9 200475
10 201361
11
[Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature].
200153
12 200451
13 202235
14 199733
15 201630
16 199629
17 200928
18 200627
19 199923
20 200923

About Guy Kantor

Guy Kantor is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Radiation, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 40 papers that have together received 2.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (17 papers), Glioma Diagnosis and Treatment (6 papers), Advanced Radiotherapy Techniques (5 papers), Vascular Malformations Diagnosis and Treatment (2 papers), Radiation Therapy and Dosimetry (2 papers), Patient-Provider Communication in Healthcare (2 papers), Adrenal and Paraganglionic Tumors (1 paper) and Medicine, History, and Philosophy (1 paper). The work is most often cited by research in Genetics (1.1k citations), Pulmonary and Respiratory Medicine (1.1k citations), Radiation (149 citations), Biomaterials (164 citations) and Oncology (174 citations). Guy Kantor has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Eberhard Stoeckle, Jean‐Michel Coindre, Binh Bui, Sylvie Bonvalot, Philippe Terrier, Hugues Loiseau, Jean‐Jacques Mazeron, Jean‐Sébastien Guillamo, Marc Frénay and Maryline Barrié. Their work appears in journals such as Radiotherapy and Oncology, The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Surgical Oncology and Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact